Login / Signup

CB1 cannabinoid receptor ligands augment the antidepressant-like activity of biometals (magnesium and zinc) in the behavioural tests.

Sylwia WośkoAnna SerefkoAleksandra SzopaPiotr WlaźAndrzej WróbelAleksandra WlaźJolanta GórskaEwa Poleszak
Published in: The Journal of pharmacy and pharmacology (2018)
The simultaneous modulation of the cannabinoid system and supplementation of magnesium or zinc produce at least additive antidepressant-like effect.
Keyphrases
  • major depressive disorder
  • oxide nanoparticles
  • binding protein